Excerpt | Relevance | Reference |
"To evaluate the efficacy and safety of 48 weeks adefovir dipivoxil (ADV) treatment for chronic hepatitis patients with cirrhosis in their decompensation period." | 9.12 | [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period]. ( Gong, ZJ; Hu, DF; Yang, Q, 2007) |
"To evaluate the efficacy and safety of 48 weeks adefovir dipivoxil (ADV) treatment for chronic hepatitis patients with cirrhosis in their decompensation period." | 5.12 | [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period]. ( Gong, ZJ; Hu, DF; Yang, Q, 2007) |